{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:44:48Z","timestamp":1792719888386,"version":"4.5.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-024-01580-4","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T23:53:41Z","timestamp":1732492421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FAP-\u03b1 is an effective tool to evaluate stroma invasion of lung adenocarcinoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Siping","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"issue":"10","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","volume":"15","author":"AL Moreira","year":"2020","unstructured":"Moreira AL, Ocampo PSS, Xia Y, Zhong H, Rusell PA, Minami Y, et al. A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol. 2020;15(10):1599\u2013610. https:\/\/doi.org\/10.1016\/j.jtho.2020.06.001.","journal-title":"J Thorac Oncol"},{"issue":"8","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/s41379-019-0257-1","volume":"32","author":"DA Moore","year":"2019","unstructured":"Moore DA, Sereno M, Das M, Baena Acevedo JD, Sinnadurai S, Smith C, et al. In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth-a clinically relevant distinction. Mod Pathol. 2019;32(8):1095\u2013105. https:\/\/doi.org\/10.1038\/s41379-019-0257-1.","journal-title":"Mod Pathol"},{"key":"1580_CR3","volume-title":"WHO classification of tumours. Thoracic tumours","author":"WHO Classification of Tumours Editorial Board","year":"2021","unstructured":"WHO Classification of Tumours Editorial Board. WHO classification of tumours. Thoracic tumours. 5th ed. Lyon: IARC; 2021.","edition":"5"},{"issue":"2","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","volume":"6","author":"WD Travis","year":"2011","unstructured":"Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International ssociation for the study of lung cancer\/American thoracic society\/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244\u201385. https:\/\/doi.org\/10.1097\/JTO.0b013e318206a221.","journal-title":"J Thorac Oncol"},{"key":"1580_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39:783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3.","journal-title":"Cancer Metastasis Rev"},{"key":"1580_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbcan.2016.11.001","volume":"186","author":"T Colangelo","year":"2017","unstructured":"Colangelo T, Polcaro G, Muccillo L, Giovanna D, Agostino V, Rosato P, Ziccardi, et al. Friend or foe? The tumour microenvironment dilemma in colorectal cancer. Biochim Biophys Acta Rev Cancer. 2017;186:1\u201318. https:\/\/doi.org\/10.1016\/j.bbcan.2016.11.001.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1580_CR7","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3390\/cancers14184394","volume":"14","author":"C Fotsitzoudis","year":"2022","unstructured":"Fotsitzoudis C, Koulouridi A, Messaritakis I, Konstantinidis T, Gouvas N, Tsiaoussis J, et al. Cancer associated fibroblasts: the origin, biological characteristics and role in cancer-a glance on colorectal cancer. Cancers. 2022;14:4394. https:\/\/doi.org\/10.3390\/cancers14184394.","journal-title":"Cancers"},{"key":"1580_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1186\/s12885-018-503","volume":"18","author":"J Liu","year":"2018","unstructured":"Liu J, Huang C, Peng C, Xu F, Li Y, Yutaka Y, et al. Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt\/\u03b2- catenin pathway. BMC Cancer. 2018;18:1099. https:\/\/doi.org\/10.1186\/s12885-018-503.","journal-title":"BMC Cancer"},{"key":"1580_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semcancer.2022.04.008","volume":"86","author":"A Peltier","year":"2022","unstructured":"Peltier A, Seban RD, Buvat I, Bidard FC, Fatima MG. Fibroblast heterogeneity in solid tumors: from single cell analysis to whole-body imaging. Semin Cancer Biol. 2022;86:262\u201372. https:\/\/doi.org\/10.1016\/j.semcancer.2022.04.008.","journal-title":"Semin Cancer Biol"},{"key":"1580_CR10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.7150\/thno.69475","volume":"12","author":"L Zhao","year":"2022","unstructured":"Zhao L, Chen J, Pang Y, Fu K, Shang Q, Wu H, et al. Fibroblast activation protein-based theranostics in cancer research: a state-of-the-art review. Theranostics. 2022;12:1557\u201369. https:\/\/doi.org\/10.7150\/thno.69475.","journal-title":"Theranostics"},{"key":"1580_CR11","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/JTO.0b013e318221f701","volume":"6","author":"PA Russell","year":"2011","unstructured":"Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011;6:1496\u2013504. https:\/\/doi.org\/10.1097\/JTO.0b013e318221f701.","journal-title":"J Thorac Oncol"},{"key":"1580_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1440-1827.2005.01782.x","volume":"55","author":"M Noguchi","year":"2005","unstructured":"Noguchi M, Minami Y, Iijima T, Matsuno Y. Reproducibility of the diagnosis of small adenocarcinoma of the lung and usefulness of an educational program for the diagnostic criteria. Pathol Int. 2005;55:8\u201313. https:\/\/doi.org\/10.1111\/j.1440-1827.2005.01782.x.","journal-title":"Pathol Int"},{"key":"1580_CR13","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/1097-0142(19930515)71:10","volume":"71","author":"JB Sorensen","year":"1993","unstructured":"Sorensen JB, Hirsch FR, Gazdar A. Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma. Cancer. 1993;71:2971\u20136. https:\/\/doi.org\/10.1002\/1097-0142(19930515)71:10.","journal-title":"Cancer"},{"key":"1580_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/modpathol.2010.232","volume":"24","author":"A Yoshizawa","year":"2011","unstructured":"Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC\/ATS\/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24:653\u201364. https:\/\/doi.org\/10.1038\/modpathol.2010.232.","journal-title":"Mod Pathol"},{"issue":"9","key":"1580_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/PAS.0000000000002075","volume":"47","author":"A Tar\u00edn-Nieto","year":"2023","unstructured":"Tar\u00edn-Nieto A, Solano-Iturri JD, Arrieta-Aguirre I, Valdivia A, Etxezarraga MC, Loizate A, et al. Fibroblast activation protein-\u03b1 (FAP) identifies stromal invasion in colorectal neoplasia. Am J Surg Pathol. 2023;47(9):1027\u201333. https:\/\/doi.org\/10.1097\/PAS.0000000000002075.","journal-title":"Am J Surg Pathol"},{"issue":"51","key":"1580_CR16","doi-asserted-by":"publisher","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","volume":"274","author":"JE Park","year":"1999","unstructured":"Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274(51):36505\u201312. https:\/\/doi.org\/10.1074\/jbc.274.51.36505.","journal-title":"J Biol Chem"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01580-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:03:01Z","timestamp":1732536181000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01580-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4473187\/v1","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"24 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Eighth Affifiliated Hospital of Sun Yat-Sen University and obtained informed consent from the study patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}